13 completed, 5 recruiting, 3 unknown. 6 Not applicable, 4 Phase 2, 2 Phase 1, 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 5, Unknown 1 |
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Phase 1 | 2 | Recruiting 2 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
Follow Juvenile Dermatomyositis: new trials by email Literature Review of Juvenile Dermatomyositis trials Research Report on Juvenile Dermatomyositis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders Descartes-08 - Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Recruiting | Cartesian Therapeutics | 50 | 2026-01-14 | 2026-07-27 |
| MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) No intervention - qualitative and mixed methods investigations - IBM, IIM | Recruiting | Myositis International Health & Research Collaborative Alliance Foundation | 700 | 2025-06-25 | 2026-01-28 | |
| Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases External Focus Exercises, Internal Focus Exercises - Juvenile Dermatomyositis, Rheumatic Diseases | Not applicable | Completed | Istanbul University - Cerrahpasa | 28 | 2025-05-01 | 2026-04-01 |
| Fitness Integrative Training for Pediatric Rheumatology Disorders FIT Teens - Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus of Childhood | Not applicable | Completed | Children's Hospital Medical Center, Cincinnati | 10 | 2024-09-24 | 2025-08-28 |
| Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis CD19-targetd CAR-T - Juvenile Dermatomyositis | Phase 1 | Recruiting | Chongqing Precision Biotech Co., Ltd | 10 | 2024-07-02 | 2024-08-26 |
| RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy CABA-201 following preconditioning with fludarabine and cyclophosphamide - Idiopathic Inflammatory Myopathy, Dermatomyositis | Phase 2 / Phase 3 | Recruiting | Cabaletta Bio | 74 | 2023-12-20 | 2026-10-15 |
| Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT) Baricitinib, pharmacokinetics study, dosage of cytokines - Juvenile Dermatomyositis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2022-11-10 | 2026-04-23 |
| Transition to Adulthood Through Coaching and Empowerment in Rheumatology Transition coaching - Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis | Not applicable | Completed | McMaster University | 26 | 2022-10-17 | 2026-02-11 |
| Juvenile Dermatomyositis Juvenile Dermatomyositis | Unknown | University Hospital, Strasbourg, France | 22 | 2018-02-08 | 2018-02-27 | |
| Incidence and Prevalence of Juvenile Dermatomyositis Juvenile Dermatomyositis | Unknown | University Hospital, Strasbourg, France | 22 | 2018-02-07 | 2018-02-14 | |
| Yellow Fever Vaccine in Patients With Rheumatic Diseases Yellow Fever vaccine (17D) - Systemic Lupus, Rheumatoid Arthritis | Not applicable | Completed | University of Sao Paulo General Hospital | 600 | 2018-01-31 | 2019-04-26 |
| Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis H.P. Acthar Gel - Dermatomyositis, Juvenile Dermatomyositis | Phase 4 | Completed | The Cleveland Clinic | 19 | 2015-06-15 | 2024-06-11 |
| The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis Creapure, Glucose Tablet - Juvenile Dermatomyositis | Not applicable | Completed | The Hospital for Sick Children | 13 | 2015-03-01 | 2018-05-11 |
| Clinical Analysis of Juvenile Dermatomyositis Patients observation - Juvenile Dermatomyositis | Completed | The First Hospital of Jilin University | 12 | 2014-01-01 | 2022-08-19 | |
| Environmental Risk Factors for the Anti-synthetase Syndrome Myositis, Dermatomyositis | Recruiting | National Institute of Environmental Health Sciences (NIEHS) | 580 | 2011-02-09 | 2026-10-16 | |
| Creatine Supplementation in Pediatric Rheumatology creatine, placebo (dextrose) - Juvenile Systemic Lupus Erythematosus, Juvenile Dermatomyositis | Not applicable | Unknown | University of Sao Paulo | 40 | 2011-01-01 | 2012-01-16 |
| The CARRA Registry Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus | Completed | Duke University | 9587 | 2009-08-01 | 2015-11-17 | |
| Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Human papilloma virus vaccine (cervarix) - Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus | Phase 4 | Completed | N.M. Wulffraat | 135 | 2009-02-01 | 2017-11-13 |
| Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis 3 MPDN pulse + PDN, 3 MPDN pulse + PDN + CSA, 3 MPDN pulse + PDN + MTX - Juvenile Dermatomyositis | Phase 3 | Completed | Istituto Giannina Gaslini | 139 | 2006-05-31 | 2023-03-28 |
| Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Rituximab, Placebo - Myositis, Dermatomyositis | Phase 2 | Completed | University of Pittsburgh | 200 | 2006-03-01 | 2015-03-04 |
Showing 20 of 21. Sign in to see all of them.
Dermatomyositis (21) · Myositis (8) · Arthritis, Juvenile (6) · Autoimmune Diseases (3) · Polymyositis (3) · Lupus Erythematosus, Systemic (2) · Mixed Connective Tissue Disease (2) · Rheumatic Diseases (2) · Scleroderma, Systemic (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Rheumatoid (1) · Exanthema (1) · Familial Mediterranean Fever (1) · Fibromyalgia (1) · Granulomatosis with Polyangiitis (1)
Connective Tissue Diseases (21) · Muscular Diseases (21) · Musculoskeletal Diseases (21) · Nervous System Diseases (21) · Neuromuscular Diseases (21) · Skin Diseases (21) · Skin and Connective Tissue Diseases (21) · Polymyositis (18) · Myositis (13) · Immune System Diseases (9) · Arthritis (6) · Autoimmune Diseases (6) · Joint Diseases (6) · Rheumatic Diseases (4) · Cardiovascular Diseases (3)
Glucose (2) · Creatine (1) · Cyclophosphamide (1) · Observation (1) · Papillomavirus Vaccines (1) · Pregnancy Tests (1) · Rituximab (1) · Yellow Fever Vaccine (1) · baricitinib (1) · fludarabine (1) · halofantrine (1) · human papillomavirus vaccine, L1 type 16, 18 (1)
University Hospital, Strasbourg, France (2) · Assistance Publique - Hôpitaux de Paris (1) · Cabaletta Bio (1) · Cartesian Therapeutics (1) · Children's Hospital Medical Center, Cincinnati (1) · Chongqing Precision Biotech Co., Ltd (1) · Duke University (1) · Istanbul University - Cerrahpasa (1) · Istituto Giannina Gaslini (1) · McMaster University (1) · Myositis International Health & Research Collaborative Alliance Foundation (1) · N.M. Wulffraat (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · National Institute of Environmental Health Sciences (NIEHS) (1) · The Cleveland Clinic (1)
United States (9) · Canada (3) · France (3) · Brazil (2) · Italy (2) · China (1) · Czechia (1) · Germany (1) · Netherlands (1) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Eloisa Bonfa, MD, PhD (2) · Adam I Schiffenbauer, M.D. (1) · Alberto Martini, MD, Prof. (1) · Ann M. Reed, MD (1) · Anthony P Fernandez, MD, PhD (1) · Bruno Gualano, PhD (1) · Carol Wallace, MD (1) · Chester V. Oddis, MD (1) · Christy Sandborg, MD (1) · Fiona van der KLis, MD, PhD (1) · Guy Berbers, PhD (1) · Hanna Kim, M.D. (1) · Laura Schanberg, MD (1) · Lesley Ann Saketkoo, MD, MPH (1)
PMID 17265499, PMID 17284544, PMID 19494218, PMID 22733975, PMID 22859354, PMID 23070991, PMID 23124935, PMID 23139240, PMID 23588937, PMID 23723319, PMID 25029335, PMID 25135060, PMID 25223501, PMID 26645190, PMID 27353816, PMID 27353819, PMID 28118536, PMID 28399931, PMID 34843469, PMID 38059274, PMID 39245937
R01AR061298 (1)